US to receive COVID-19 vaccine for risk groups in December

“Help is on the way.

A vaccine appeared on the horizon.

The vaccine will be available for high priority people in mid to late December, ”he told ABC.

Earlier, the German company BioNTech and the American pharmaceutical corporation Pfizer announced that their vaccine against coronavirus was 95% effective.

At the same time, the interim results of the third phase of trials of the COVID-19 vaccine of the American company Moderna showed an efficiency of 94.5%.

The White House said that by the end of 2020, 40 million doses of coronavirus vaccine will be available in the United States.

At the same time, US President Donald Trump announced that the American coronavirus vaccine will be available to the country's population in April next year.